Nestlé plays down big deals
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Nestlé chief executive officer Mark Schneider has hinted that a move for either Pfizer’s or Merck KGaA’s OTC business is not realistic so soon after signing a deal to snap up dietary supplements specialist Atrium Innovations.